Identification and Comparison of Foxp3 in Women with Recurrent Spontaneous Abortion and Controls

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Immunology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Associate Professor, Department of Immunology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Assistant Professor, Department of Parasitology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Background: Recurrent spontaneous abortion (RSA), defined as two or more consecutive pregnancy losses before the 20th week of gestation. Foxp3 is a regulatory T-cell-dependent transcription factor that is essential for function of these cells. The aim of this study was to identify the polymorphism Foxp3 (-3279) gene in the women with recurrent abortion and controls.Methods: In this case-control study, 80 women with history of at least two spontaneous abortion before the 20th week of gestation determined as case; they were negative for genetic, infectious, anatomic and hormonal disorders. Eighty non-pregnant healthy women with no history of abortion and having at least one child that referred to Yazd centeral laboratory for check-up were selected as control. The Foxp3 gene 3279 polymorphism using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was performed. Data analysis was performed by chi-square.Findings: The frequency of CC, AC and AA genotypes were 58.8, 25, and 16.2 percent in women with RSA and 52.5, 21.2 and 26.2 percent in controls, respectively. No significant difference was found between the groups (P = 0.3).Conclusion: In this study, a statistically significant difference was not seen in the prevalence of polymorphisms rs3761548C/A between control and recurrent abortion groups.

Keywords


  1. Regan L. Overview of recurrent miscarriage. Gynaecol Forum 1998; 3: 3-7.
  2. Arefi S, Jeddi Tehrani M, Ghaffari Novin M, Sadeghpour Tabaie A. New edition of recurrent abortion syndrome. Tehran, Iran: Teimourzadeh; 2004. p. 31-56. [In Persian].
  3. Mei S, Tan J, Chen H, Chen Y, Zhang J. Changes of CD4+CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril 2010; 94(6): 2244-7.
  4. Wu Z, You Z, Zhang C, Li Z, Su X, Zhang X, et al. Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin Dev Immunol 2012; 2012: 896458.
  5. Lee RM, Silver RM. Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 2000; 18(4): 433-40.
  6. Clark DA. Anti-TNFalpha therapy in immune-
  7. mediated subfertility: state of the art. J Reprod Immunol 2010; 85(1): 15-24.
  8. Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin Immunopathol 2006; 28(1): 31-9.
  9. Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon BA, Fest S, et al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol 2006; 36(1): 82-94.
  10. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10(5): 347-53.
  11. Yang H, Qiu L, Chen G, Ye Z, Lu C, Lin Q. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril 2008; 89(3): 656-61.
  12. Leber A, Teles A, Zenclussen AC. Regulatory T cells and their role in pregnancy. Am J Reprod Immunol 2010; 63(6): 445-59.
  13. Inoue N, Watanabe M, Morita M, Tomizawa R, Akamizu T, Tatsumi K, et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol 2010; 162(3): 402-6.
  14. Gao L, Li K, Li F, Li H, Liu L, Wang L, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010; 57(1): 51-6.
  15. Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum Immunol 2009; 70(11): 930-4.
  16. Bassuny WM, Ihara K, Sasaki Y, Kuromaru R, Kohno H, Matsuura N, et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 2003; 55(3): 149-56.
  17. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004; 112(1): 38-43.
  18. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27(1): 68-73.
  19. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445(7129): 766-70.
  20. Lin YC, Lee JH, Wu AS, Tsai CY, Yu HH, Wang LC, et al. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus 2011; 20(2): 137-43.
  21. Shen Z, Chen L, Hao F, Wang G, Liu Y. Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding. J Cell Mol Med 2010; 14(1-2): 226-41.